In contrast, GnRH-ant competitively blocks GnRH receptors and rapidly inhibits the release of gonadotropin (Gn) [5], reducing the risk of ovarian hyperstimulation syndrome. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.